Compare AbCellera Biologics Inc (ABCL) vs Enbridge Inc (ENB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Enbridge Inc — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Enbridge Inc trades at $51.74 (market cap $112.62B). The key difference: Enbridge Inc is far larger — about 37.7× AbCellera Biologics Inc's market cap, and Enbridge Inc pays a 5.34% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | ENB | |
|---|---|---|
Market Cap | $2.99B | $112.62B |
Sector | Health | Energy |
52-Week High | $9.76 | $58.04 |
52-Week Low | $2.78 | $45.23 |
Enterprise Value | $2.58B | $196.53B |
Dividend Yield | — | 5.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →
